SENSEI BIOTHERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6698 USD | +3.00% |
|
-8.01% | -3.21% |
| May. 14 | Stephens Starts Sensei Biotherapeutics With Overweight Rating, $5 Price Target | MT |
| May. 09 | Sensei Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar Sensei Biotherapeutics, Inc.
93ce747a42fee7fe9.0BBixug8YHm2tnHqtHZubZC5KCCSjLv2M9CDLmQxcrg.43YytdF7L07V7iu59TtXBdjdSXTb5o-TZOWzdytdA-exUiiQgkQGFvX3PA~ac6ab4e158e2bc04479de607858a24ac
Upcoming events on Sensei Biotherapeutics, Inc.
Past events on Sensei Biotherapeutics, Inc.
| 2024-06-06 08:30 am | Jefferies Global Healthcare Conference |
| 2024-06-03 08:00 am | Business Update Call |
| 2024-06-01 10:00 am | American Society of Clinical Oncology Meeting - Abstract Number: 2600 |
| 2024-05-09 07:30 am | Q1 2024 Earnings Release |
| 2024-04-15 02:00 pm | CG Horizons in Oncology Virtual Conference - Panel |
| 2024-04-09 04:30 pm | American Association for Cancer Research Meeting - Abstract No - 5294 |
| 2024-03-27 11:00 am | VISTA Symposium |
| 2024-03-20 10:30 pm | Keystone Symposia Cancer Immunotherapy Meeting - Poster Number - 3021 |
| 2024-03-19 06:00 pm | Keystone Symposia Cancer Immunotherapy Meeting - VISTA checkpoint targeting by SNS 101 |
| 2024-02-29 11:10 am | Immuno Oncology 360 Conference |
| 2024-02-28 07:30 am | Q4 2023 Earnings Release |
| 2024-02-14 10:00 am | Oppenheimer Healthcare Life Sciences Conference |
| 2023-11-14 11:00 am | Protein & Antibody Engineering Summit |
| 2023-11-13 | Jefferies London Healthcare Conference |
| 2023-11-07 07:30 am | Q3 2023 Earnings Release |
| 2023-11-04 12:00 pm | Society for Immunotherapy of Cancer Meeting - Abstract No - 1532 |
| 2023-09-21 06:30 am | CRI ENCI AACR International Cancer Immunotherapy Conference |
| 2023-09-05 | Wells Fargo Healthcare Conference |
| 2023-09-04 | Citi Biopharma Conference |
| 2023-08-09 09:30 am | Canaccord Genuity Growth Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -19,2 -19,0 -1.27% | -36,8 -39,0 5.65% | -49,6 -48,6 -1.97% | -36,5 -36,2 -0.74% | -36,9 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -19,5 -19,2 -1.27% | -37,5 -38,8 3.29% | -50,2 -49,5 -1.33% | -37,1 -37,4 0.79% | -38,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -20,1 -18,8 -7.16% | -36,8 -38,0 3.08% | -48,6 -48,9 0.69% | -34,1 -34,3 0.67% | -34,3 |
|
Net income Million USD | Released Forecast Spread | -16,7 | -20,2 -19,6 -3.05% | -36,8 -37,9 3.03% | -48,6 -49,0 0.87% | -34,1 -34,4 0.94% | -35,2 |
|
EPS USD | Released Forecast Spread | -1,16 | -12,5 -4,92 -154.5% | -1,33 -1,32 -0.5% | -1,58 -1,60 0.94% | -1,22 -1,24 1.21% | -1,13 |
| Announcement Date | 15/01/21 | 25/03/21 | 10/03/22 | 28/03/23 | 28/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -8,01 -7,74 -3.47% | -8,59 -8,33 -3.17% | -8,95 | -9,38 | -10,0 | |||||||
|
EBIT Million USD | Released Forecast Spread | -12,5 -10,9 -15.09% | -10,7 -11,9 9.98% | -13,9 -11,0 -26.74% | -13,0 -12,5 -4.38% | -11,0 -11,0 -0.07% | -10,2 -10,8 5.33% | -7,74 -9,25 16.36% | -8,14 -8,44 3.48% | -8,73 -8,10 -7.78% | -9,13 | -9,71 | -10,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -12,4 -10,5 -18.14% | -13,4 -12,0 -11.8% | -12,2 -12,5 2.14% | -7,41 -7,64 3.01% | -7,99 -7,66 -4.33% | -8,30 | -8,83 | -9,20 | ||||
|
Net income Million USD | Released Forecast Spread | -12,4 -10,8 -14.86% | -10,5 -11,8 10.72% | -13,4 -10,8 -24.22% | -12,2 -12,4 1.35% | -10,2 -10,8 5.77% | -9,39 -10,0 6.14% | -7,12 -8,50 16.19% | -7,41 -7,74 4.19% | -7,99 -6,84 -16.77% | -8,41 | -9,06 | -9,71 |
|
EPS USD | Released Forecast Spread | -0,40 -0,35 -14.29% | -0,34 -0,38 10.53% | -0,44 -0,35 -25.71% | -0,40 -0,41 1.23% | -0,33 -0,35 5.71% | -0,31 -0,32 3.13% | -0,28 -0,28 0% | -0,30 -0,32 4.76% | -0,32 -0,29 -10.34% | -0,29 | -0,28 | -0,29 |
| Announcement Date | 10/05/22 | 09/08/22 | 08/11/22 | 28/03/23 | 09/05/23 | 03/08/23 | 07/11/23 | 28/02/24 | 09/05/24 | - | - | - |
More events
Past sector events for Sensei Biotherapeutics, Inc.
| 2024-06-05 03:51 am | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
| 2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 2024-05-15 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
| 2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 04:00 pm | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SNSE Stock
- Calendar Sensei Biotherapeutics, Inc.
